Drug Profile
Research programme: beta-amyloid vaccine - Merck
Alternative Names: Anti-Aβ vaccine - MerckLatest Information Update: 26 Aug 2011
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 26 Aug 2011 No development reported - Preclinical for Alzheimer's disease in USA (Injection)
- 02 Nov 2006 Preclinical trials in Alzheimer's disease in USA (Injection)